Sustiva



Indications and Reactions:

Role Indications Reactions
Primary
Hiv Infection 66.4%
Antiretroviral Therapy 11.6%
Tuberculosis 6.9%
Prophylaxis Against Transplant Rejection 2.3%
Hiv Test Positive 1.7%
Prophylaxis 1.7%
Pathogen Resistance 1.2%
Hypertension 1.0%
Acquired Immunodeficiency Syndrome 0.9%
Antifungal Prophylaxis 0.9%
Meningitis Tuberculous 0.7%
Type 2 Diabetes Mellitus 0.6%
Antiviral Prophylaxis 0.6%
Depression 0.6%
Infection 0.6%
Hiv Test 0.5%
Mycobacterial Infection 0.5%
Adverse Event 0.5%
Atypical Mycobacterial Infection 0.5%
Cerebral Toxoplasmosis 0.5%
Pregnancy 34.2%
Drug Screen False Positive 7.3%
Vomiting 6.8%
Drug Screen Positive 5.9%
Rash 4.9%
Adverse Event 4.2%
Pyrexia 3.7%
Thrombocytopenia 3.4%
Myocardial Infarction 3.2%
Vertigo 3.2%
Nervous System Disorder 2.9%
Urine Colour Abnormal 2.7%
Nightmare 2.4%
Weight Decreased 2.4%
Death 2.2%
Medication Residue 2.2%
Somnolence 2.2%
Ventricular Septal Defect 2.2%
Immune Reconstitution Syndrome 2.0%
Insomnia 2.0%
Secondary
Hiv Infection 60.3%
Drug Use For Unknown Indication 8.2%
Antiretroviral Therapy 6.3%
Tuberculosis 5.7%
Antiviral Treatment 3.2%
Drug Exposure During Pregnancy 2.9%
Product Used For Unknown Indication 2.8%
Prophylaxis 1.6%
Hiv Test Positive 1.2%
Antifungal Prophylaxis 1.2%
Depression 1.1%
Hypertension 0.9%
Antiviral Prophylaxis 0.9%
Pain 0.7%
Medical Diet 0.6%
Acquired Immunodeficiency Syndrome 0.5%
Anaemia 0.5%
Maternal Exposure Timing Unspecified 0.5%
Prophylaxis Against Transplant Rejection 0.5%
Prophylaxis Against Hiv Infection 0.5%
Drug Exposure During Pregnancy 9.9%
Pyrexia 9.9%
Abortion Spontaneous 7.0%
Weight Decreased 6.7%
Renal Failure 6.3%
Thrombocytopenia 6.0%
Vomiting 5.6%
Pregnancy 5.3%
Microcephaly 4.9%
Neutropenia 4.9%
Myocardial Infarction 3.9%
Progressive External Ophthalmoplegia 3.9%
Stillbirth 3.5%
Varices Oesophageal 3.5%
Completed Suicide 3.2%
Hepatotoxicity 3.2%
Rash 3.2%
Renal Failure Acute 3.2%
Urogenital Disorder 3.2%
Ectopic Pregnancy 2.8%
Concomitant
Hiv Infection 55.8%
Drug Use For Unknown Indication 10.1%
Drug Exposure During Pregnancy 7.3%
Product Used For Unknown Indication 4.2%
Pain 2.9%
Depression 2.6%
Tuberculosis 2.1%
Hypertension 2.0%
Hepatitis C 1.9%
Insomnia 1.5%
Acquired Immunodeficiency Syndrome 1.4%
Disseminated Tuberculosis 1.4%
Hiv Test Positive 1.2%
Prophylaxis 1.2%
Chronic Obstructive Pulmonary Disease 0.8%
Arthritis 0.8%
Nausea 0.8%
Pulmonary Hypertension 0.8%
Anxiety 0.7%
Antiretroviral Therapy 0.6%
Renal Failure Acute 9.3%
Viral Load Increased 8.4%
Rash 8.0%
Vomiting 8.0%
Weight Decreased 7.5%
Renal Failure 6.2%
Thrombocytopenia 5.8%
Ventricular Septal Defect 4.9%
Pregnancy 4.4%
Rectal Haemorrhage 4.4%
Nausea 4.0%
Abortion Spontaneous 3.5%
Osteonecrosis 3.5%
Renal Tubular Disorder 3.5%
Haemoglobin Decreased 3.1%
Pancreatitis 3.1%
Pancreatitis Acute 3.1%
Spinal X-ray Abnormal 3.1%
Squamous Cell Carcinoma 3.1%
Suicidal Ideation 3.1%
Interacting
Hiv Infection 30.8%
Product Used For Unknown Indication 30.8%
Drug Use For Unknown Indication 26.9%
Acquired Immunodeficiency Syndrome 9.6%
Thrombophlebitis 1.9%
Renal Tubular Necrosis 21.4%
Unevaluable Event 21.4%
Pregnancy 14.3%
Drug Ineffective 7.1%
Neuropathy Peripheral 7.1%
Pulmonary Embolism 7.1%
Tearfulness 7.1%
Visual Acuity Reduced 7.1%
Vomiting 7.1%